Iae. Function in expression of cell-type-specific genes. Mol Gen Genet. 1994; 243:315?24. [PubMed: 8043104] 23. Messenguy F, Dubois E. Genetic proof to get a part for MCM1 within the regulation of arginine metabolism in Saccharomyces cerevisiae. Mol Cell Biol. 1993; 13:2586?592. [PubMed: 8455631] 24. Shen X, Xiao H, Ranallo R, Wu WH, Wu C. Modulation of ATP-dependent chromatin-remodeling complexes by inositol polyphosphates. Science. 2003; 299:112?14. [PubMed: 12434013] 25. Steger DJ, Haswell ES, Miller AL, Wente SR, O’Shea EK. Regulation of chromatin remodeling by inositol polyphosphates. Science. 2003; 299:114?16. [PubMed: 12434012] 26. Nalaskowski MM, Deschermeier C, Fanick W, Mayr GW. The human homologue of yeast ArgRIII protein is definitely an inositol phosphate multikinase with predominantly nuclear localization. Biochem J. 2002; 366:549?56. [PubMed: 12027805] 27. Resnick AC, Snowman AM, Kang BN, Hurt KJ, Snyder SH, Saiardi A. Inositol polyphosphate multikinase is often a nuclear PI3-kinase with transcriptional regulatory activity. Proc Natl Acad Sci USA. 2005; 102:12783?2788. [PubMed: 16123124] 28. Gordaliza M, Garc PA, del Corral JM, Castro MA, G ez-Zurita MA. Podophyllotoxin: Distribution, sources, applications and new cytotoxic derivatives. Toxicon. 2004; 44:441?59. [PubMed: 15302526] 29. Hande KR. Etoposide: Four decades of development of a topoisomerase II inhibitor. Eur J Cancer. 1998; 34:1514?521. [PubMed: 9893622] 30. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B. WAF1, a prospective mediator of p53 tumor suppression. Cell. 1993; 75:817?25. [PubMed: 8242752]NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author ManuscriptSci Signal. Author manuscript; out there in PMC 2014 July 23.Xu et al.Page31. Miyashita T, Reed JC. Tumor suppressor p53 is usually a direct transcriptional activator from the human bax gene. Cell. 1995; 80:293?99. [PubMed: 7834749] 32. Nakano K, Vousden KH. PUMA, a novel proapoptotic gene, is induced by p53. Mol Cell. 2001; 7:683?94. [PubMed: 11463392] 33. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo having a conserved homolog, Bax, that accelerates programmed cell death. Cell. 1993; 74:609?19. [PubMed: 8358790] 34. Yu J, Wang Z, Kinzler KW, Vogelstein B, Zhang L. PUMA mediates the apoptotic response to p53 in colorectal cancer cells. Proc Natl Acad Sci USA. 2003; 100:1931?936. [PubMed: 12574499] 35. Longley DB, Harkin DP, Johnston PG. 5-Fluorouracil: Mechanisms of action and clinical strategies. Nat Rev Cancer.Formula of 109781-47-7 2003; three:330?38.Ethyl 2-chloro-2-(hydroxyimino)acetate web [PubMed: 12724731] 36. Tan C, Tasaka H, Yu KP, Murphy ML, Karnofsky DA.PMID:33649992 Daunomycin, an anti-tumor antibiotic, in the therapy of neoplastic illness. Clinical evaluation with particular reference to childhood leukemia. Cancer. 1967; 20:333?53. [PubMed: 4290058] 37. Barlev NA, Liu L, Chehab NH, Mansfield K, Harris KG, Halazonetis TD, Berger SL. Acetylation of p53 activates transcription through recruitment of coactivators/histone acetyltransferases. Mol Cell. 2001; eight:1243?254. [PubMed: 11779500] 38. Gu W, Roeder RG. Activation of p53 sequence-specific DNA binding by acetylation of the p53 Cterminal domain. Cell. 1997; 90:595?06. [PubMed: 9288740] 39. Liu L, Scolnick DM, Trievel RC, Zhang HB, Marmorstein R, Halazonetis TD, Berger SL. p53 internet sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol. 1999; 19:1202?209. [PubMed: 9891054] 40. Tang Y, Zhao W, Chen Y, Zhao Y, Gu W. Acety.